Explore our tests
Discover the right genetic test for your patient in our complete list of tests and panels.
Showing 10 out of 406 tests
Multiple Endocrine Neoplasia Type 2A (MEN2A), Type 2B (MEN2B), and Familial Medullary Thyroid Carcinoma (FMTC) via the RET Gene
NGS with CNV (PGselect Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 4673
2 - 3 weeks (7 - 16 days STAT)•Test 46731 Gene
Multiple Epiphyseal Dysplasia Panel
NGS with CNV (Exome or Genome Platform)2 - 3 weeks (6 - 12 days STAT)•Test 10247
2 - 3 weeks (6 - 12 days STAT)•Test 1024710 Genes
My Retina Tracker Program
Sponsored TestNGS with CNV (PGselect Platform)2 - 3 weeks•Test 16023
2 - 3 weeks•Test 16023110 Genes
NavigATTR Sponsored Testing Program
Sponsored TestNGS with CNV (PGselect Platform)2 - 3 weeks•Test 15139
2 - 3 weeks•Test 151391 Gene
Nemaline Myopathy (NEM2) via the Nebulin (NEB) Gene
NGS with CNV (Exome or Genome Platform)2 - 3 weeks (7 - 16 days STAT)•Test 1772
2 - 3 weeks (7 - 16 days STAT)•Test 17721 Gene
Nemaline Myopathy via the NEB Exon 55 Deletion
Targeted PCR2 - 3 weeks (8 - 10 days STAT)•Test 356
2 - 3 weeks (8 - 10 days STAT)•Test 3561 Gene
Nemaline Myopathy via the NEB Gene, Exons 82-105 (Triplicate Repeat Region)
Sanger Sequencing3 - 4 weeks (12 - 19 days STAT)•Test 2079
3 - 4 weeks (12 - 19 days STAT)•Test 20791 Gene
Neonatal Respiratory Distress Panel
NGS with CNV (Exome or Genome Platform)2 - 3 weeks (6 - 12 days STAT)•Test 13349
2 - 3 weeks (6 - 12 days STAT)•Test 133495 Genes
Nephrolithiasis and Nephrocalcinosis Panel
NGS with CNV (Exome or Genome Platform)2 - 3 weeks (6 - 12 days STAT)•Test 10395
2 - 3 weeks (6 - 12 days STAT)•Test 1039530 Genes
Nephrotic Syndrome (NS)/Focal Segmental Glomerulosclerosis (FSGS) Panel
NGS with CNV (Exome or Genome Platform)2 - 3 weeks (7 - 16 days STAT)•Test 10417
2 - 3 weeks (7 - 16 days STAT)•Test 1041772 Genes